Tapentadol intranasal - Torrent Pharmaceuticals
Latest Information Update: 26 May 2016
At a glance
- Originator Torrent Pharmaceuticals
- Class Opioid analgesics; Phenols; Small molecules
- Mechanism of Action Adrenergic uptake inhibitors; Alpha 2 adrenergic receptor antagonists; Opioid mu receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Pain
Most Recent Events
- 26 May 2016 Chemical information added
- 24 May 2016 Phase-I development is ongoing in India